Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Knee Osteoarthritis
NCT05160831Unknown
- Sponsor
- Southwest Health System
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Stem Cell Therapies
01
Overview
Open-label, single-arm trial of human umbilical cord mesenchymal stem cells in knee osteoarthritis (OA), sponsored by Southwest Health System. Primary endpoint: Visual Analog Scale at 12 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05160831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160831.